Hide Board Information

Show Board Information

Clene Inc. CLNN

Board Mod: Add me as mod

Asst Mods:

Last Post: 07/18/2025 4:48:48 PM

Board Marks: 0

Posts Today: 1

Board Views Today: 81

Clene Inc. (NASDAQ: CLNN) Stock Message Board

1. CLNN Company Profile

    

2. CLNN Time & Sales

    

3. CLNN Recent News

    

4. CLNN Filings

    

5. CLNN Financials

    

6. CLNN Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

10	NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN)	NetworkNewsWire	10/17/2023 5:19:45 PM
9	Clene Inc. (NASDAQ: CLNN) Applies Patented	NetworkNewsWire	10/16/2023 5:10:19 PM
8	NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN)	NetworkNewsWire	10/10/2023 4:30:43 PM
7	NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN)	NetworkNewsWire	10/05/2023 3:58:35 PM
5	Unveiling the Neuroprotective Power of CNMAu8 A	NetworkNewsWire	09/29/2023 5:17:42 PM
4	Clene Inc. (NASDAQ: CLNN) Is One to Watch -	NetworkNewsWire	09/28/2023 4:31:02 PM
3	NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN)	NetworkNewsWire	09/28/2023 4:19:23 PM
2	NetworkNewsBreaks Clene Inc. (NASDAQ: CLNN)	NetworkNewsWire	09/25/2023 4:08:09 PM
1	CLNN 43% v39M c4.13 f63,3M H4.30 ML:2.28 gap	znewcar1	07/14/2022 4:27:05 PM

Newer

Recent Articles

• Karan Raturi Joins D2E Labs as COO to Enhance Marketplace Success
• Discover Midas Immersion Cooling's TCO Calculator for Savings
• Cleveland-Cliffs Inc. Faces Serious Class Action Scrutiny
• Genius Act Sparks Interest in Coinbase and Robinhood Stocks
• Pyrophyte Acquisition Corp. II Completes Successful IPO Journey
• Matador Technologies Announces New CTO and Strategic Plans
• Robot Consulting Co. Opens New Chapter with $15 Million IPO
• Brookfield Renewable Enhances Commitment with Increased Investment
• Bowen Acquisition Corp Faces NASDAQ Delisting Risk Amid Non-Compliance
• Gray Media Completes $900 Million Offering of Secured Notes
• Ultragenyx Pharmaceutical Expands Team with Stock Award Grant
• AYR Wellness Extends Waiver Agreement to Strengthen Operations
• Gray Media Expands Credit Facility and Restructures Debt Obligations
• Remarkable Growth of Texas Instruments Over a Decade
• Fortrea Holdings Faces Class Action: How Investors Can Respond
• Brookfield Renewable's Strategic Investment Bolsters Hydro Assets
• Transforming $100 Into $255 With Ferguson Enterprises
• AYR Wellness Strengthens Financial Flexibility with Waiver Extension
• Understanding Devon Energy's Short Interest Trends and Insights
• Analyzing Market Sentiment Around Verona Pharma's Stock
• Exploring American Express's Current Market Dynamics and Trends
• Radiate Holdco, LLC Announces 2024 Financial Performance Update
• American Express Reports Strong Earnings Amid Stablecoin Uncertainties
• Netflix's Second Quarter Growth: Is It a Time to Invest?
• Rogers Communications Unveils Cash Tender Offers for Debt Securities
• Wall Street Surges as Major Corporations Drive Optimism
• Visa's Strategic Moves Indicate Potential for Investors in V
• Virax Biolabs Navigates Nasdaq Compliance Challenges
• Bank of America Announces Upcoming Preferred Stock Dividends
• Midas Immersion Cooling Launches Advanced Maintenance Tools
• Navigating Market Dynamics: Nasdaq 100 Insights and Updates
• Analyzing Netflix's Q2 2025 Earnings and Future Prospects
• Talen Energy Corporation Expands Power Portfolio Significantly
• Humana Faces Setbacks After Legal Ruling on Medicare Payments
• MicroStrategy Stock's Unexpected Decline Amid Positive Crypto News
• Almadex Minerals Wraps Up Successful Gold Loan Repayment
• NEO Battery Materials Secures Final Tranche of Funding
• HPQ Silicon Board Approves Cancellation of Stock Options
• Capricor Therapeutics Addresses Recent Class Action Lawsuit
• NEO Battery Materials Finalizes Successful Private Placement Tranche
• Transforming $100 into $743 in Starbucks Shares Over 20 Years
• Cytokinetics Expands Employee Incentives with Stock Options
• Vor Bio's New Stock Option Grant: A Step Towards Growth
• Red Cat Holdings: Investor Alert on Legal Claims for Loss Recovery
• HOOKIPA Pharma Plans to Delist from Nasdaq Amid Changes
• Exploring Delta Air Lines: Performance Insights and P/E Analysis
• Exploring Recent Trends in Apple Inc.'s Options Activity
• Understanding Tempus AI's Options Trading Activities
• Exploring Duolingo's Options Trading and Market Insights
• Sarepta Therapeutics Faces Class Action for Alleged Fraud